% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • immediatereliefxxx immediatereliefxxx Aug 15, 2013 9:00 AM Flag

    Today at Cannacord: coming out fighting

    Report on today's conference call:

    Both CEO Chris Garabedian and CMO Ed Kaye participated. They came out fighting, for the first time addressing the slanders made against their science by an unfortunately influential blogger. They detailed for the investing community the extremely sensitive measures they have used to measure dystrophin in biopsies. They defended immunofluorescence as the gold standard and dismissed the Western Blot as outdated and less sensitive.

    Ed Kaye is particularly impressive. The man is a giant in the field.

    They also discussed manufacturing progress (still good), the FDA (unprecedented interest by the highest officers) and mentioned that not one eteplirsen patient has declined more than 3% from baseline.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
25.28+0.62(+2.51%)4:00 PMEDT